| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |